US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
Factset Research Systems (1FDS) 銘柄情報

Factset Research Systems (1FDS)

0.00

0.00

(0.00%)

終了 7月4日 12:30AM

Factset Research Systems (1FDS) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

-

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

955,271 €

発行済株式数

35,565,543

配当利回り

4.46 (1.89%)

PER

16.17

1 株当たり利益 (EPS)

15.19

歳入

2.44B

純利益

565.97M

FactSet Research Systems Inc., together with its subsidiaries, operates as a financial digital platform and enterprise solutions provider for the investment community. It offers data, products, and analytical applications; and workstations, portfolio analytics, and enterprise data solutions, as well... FactSet Research Systems Inc., together with its subsidiaries, operates as a financial digital platform and enterprise solutions provider for the investment community. It offers data, products, and analytical applications; and workstations, portfolio analytics, and enterprise data solutions, as well as managed services for supporting data, performance, risk, and reporting workflows. The company also provides subscription-based financial data and market intelligence on securities, companies, industries, and people that enable clients to research investment ideas, as well as analyze, monitor, and manage portfolios; and solutions covering investment lifecycle of investment research, portfolio construction and analysis, trade execution, performance measurement, risk management, and reporting. In addition, it offers services through configurable desktop and mobile platform, data feeds, cloud-based digital solutions, and application programming interfaces. It operates in Europe, the Middle East, Africa, the Americas, the Asia Pacific, and internationally. The company serves investment professionals, including institutional asset managers, bankers, wealth managers, asset owners, partners, hedge funds, corporate users, and private equity and venture capital professionals. It has a strategic partnership with Google Cloud to create a new generation of AI-powered solutions for the financial industry. FactSet Research Systems Inc. was founded in 1978 and is headquartered in Norwalk, Connecticut. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.factset.com

本社

Norwalk, United States

設立

1978

Factset Research Systems is listed in the sector of the イタリア証券取引所 with ticker 1FDS. The last closing price for Factset Research Systems was -. Over the last year, Factset Research Systems shares have traded in a share price range of 0.00 € to 0.00 €.

Factset Research Systems currently has 35,565,543 shares in issue. Factset Research Systems has a price to earnings ratio (PE ratio) of 16.17.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

1FDS - Frequently Asked Questions (FAQ)

What is the current Factset Research Systems share price?

The current share price of Factset Research Systems is 0.00 €

How many Factset Research Systems shares are in issue?

Factset Research Systems has 35,565,543 shares in issue

What is the 1 year trading range for Factset Research Systems share price?

Factset Research Systems has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Factset Research Systems?

The price to earnings ratio of Factset Research Systems is 16.17

What is the cash to sales ratio of Factset Research Systems?

The cash to sales ratio of Factset Research Systems is 3.58

What is the registered address of Factset Research Systems?

The registered address for Factset Research Systems is 45 Glover Avenue, Norwalk, Connecticut, 06850

What is the Factset Research Systems website address?

The website address for Factset Research Systems is www.factset.com

jammy32

jammy32 7分前

He’s not in a hurry so I don’t think he cares. Million a year. 250 million shares that he can take tax free loans on. 90 million more shares coming his way at 15 cents. 5 million bonus. 5,000 per month spending money on his Benz. Life is good for the Nasrat cabal. My opinion

100lbStriper

100lbStriper 7分前

If the lengthy qualification process involving Netlist’s Lightning DDR5 products and a major global server OEM is indeed approaching completion, the company could be transitioning from years of investment and validation into the commercial harvesting phase management has been working toward.

sandor8

sandor8 10分前

As I , previously, said He knows how to do it, already done several times in his life.
Mr Kraig and us we'll make IT !!!!!
I am fully confident in him and me, I can sense it.
Doubters relax or get out for your own mental health.

trunkmonk

trunkmonk 10分前

while the debt has gone up 10x, and M2 multiples of that, the 50 year super cycle must finish its course. final price 33k.
and while most everyone just keeps getting poorer, Perot and his decedents keep getting wealthier. they still dominate in DFW, not public companies, but an Empire built b

HoldHigh

HoldHigh 12分前

I've been by that facility also and it is very large.

PennyMillions852

PennyMillions852 13分前

.003 break is needed, Peanutzz already making wild Claims a .05 looking stupid as that was said before and got us know where, pipe down and crawl before you can walk pumper!!!

brazen22

brazen22 13分前

Doc, I do not speak for MHRA. But neither do you. You packed manufacturing, NHS budgets, Specials, Flaskworks, future demand, and Monday trading volume into one post, so yes, some explanation is warranted.

You keep saying “manufacturing, manufacturing, manufacturing,” but Bosch’s pres

HoldHigh

HoldHigh 15分前

From an article on MJbiz : What cannabis products are available at Georgia pharmacies?

Currently, the state limits business licenses to:
Six cultivation licenses
15 retail licenses, six of which are held by Trulieve
One independent cannabis testing laboratory

Taleb Spinoza

Taleb Spinoza 19分前

It may be a dead cat now, but it is sitting in my crab pot. I’ll be back when I’m done making my rounds. When I eventually pull it up it may be loaded with delicious crab.

Mr.Jones

Mr.Jones 25分前

Regarding options 1, 2, and 3. If in option 1 we merged with a Nasdaq company over $4 a share that would be fine. If they were under $4 a share, wouldn't we have to have a reverse split if we merged? In addition, wouldn't we need a reverse split in option 2 as well if we acquire a company under $1 a

Doc logic

Doc logic 26分前

JerryCampbell,

It was stated that the MAA submitted allowed for introduction of this patient level data IF it became available. So addendum, since you are trying to figure out the time involved, which I think that they believed might become available IF there was enough time elapsing

Miamifl

Miamifl 28分前

Wishing everyone a safe holiday and a good time with your family!!!

EternalPatience

EternalPatience 28分前

Our long awaited day of reckoning is here and most likely will come and go silently but we will go through the motion with slight hope and meet again at the end of the day

1kgwxman

1kgwxman 29分前

Not a chance...🤣

If it is...(806)-742-3767
Call Texas Tech.
Call Nelson.
Call the state of Texas.
That won't happen, because there's nothing to offer besides griping and whining.

If you think AMFN is a scam, then...

1.

male2

FOMO and short panic and fear are the reason why people will never make good money in anything.if you can’t see the fundamentals and hold during a bad period then you should just go do options or leave stocks alone.

JettaR

JettaR 38分前

Even the fake news and three amigos have disappeared

CanItBThisEZ2Make

CanItBThisEZ2Make 41分前

BEST SELLERS RANK (BSR) IS 332 3 Estimated Sold on Amazon Since JULY 1 - 3RD Quarter 2026
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec

audreyperez

audreyperez 43分前

The interesting line here is that 98% of small molecules and almost all biologics fail to cross the BBB. That reframes the whole CNS space. Most retail investors read an Alzheimer's headline and chase whichever company has the loudest trial readout, but if the article is right, the real bottleneck w

VVVVVV

VVVVVV 48分前

“Perhaps you’d like to explain why they filed them in the first place, then, only to withdraw them later”.

No I wouldn’t, because you wouldn’t be able to comprehend it. There’s a number of perfectly good reasons why. You’ll just have to figure it out on your own..

rosemountbomber

rosemountbomber 49分前

Need two more days with a close above a buck. Let's go.

joeycav11

joeycav11 53分前

You constantly say manufacturing, manufacturing, manufacturing......You know what would expedite manufacturing? The dollars that would roll in once we had approval. Approval brings eyes money and partnerships. Nwbo can't be expected to do it all alone.
So approve first and then tackle manufac

BigBadWolf

BigBadWolf 53分前

N/C n 62 days T/A verified Authorized Shares 12,000,000,000 07/03/2026
Outstanding Shares 9,075,744,139 07/03/2026
Restricted 451,444,523 07/03/2026
Unrestricted 8,624,299,616 07/03/2026
Held at DTC 8,588,090,296 07/03/2026

Authorized Shares 12,000,000,000

rosemountbomber

rosemountbomber 54分前

A guess a question to any and all here. Any of you use Fidelity as a broker? For those of you who do, are you familiar with when you do research on a stock, Fidelity provides what they call an "Equity Summary Score" provided by LSEG StarMine. That score is in a form of a number ranging from 0 to

E30

Scott Bessent is the problem he doesn't want to release look at his previous business adventures / businesses

Factset Research Systems

Amundi S&P 500 Swap UCIT...

Laan and Spar Ban

BetterLife Pharma

Highbank Resources

Exchange Income (PK)

Rapport Therapeutics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。